CDx Diagnostics®
Brendan McGuire has over 15 years of experience in sales and market development within the medical technology and consulting sectors. Currently serving as Regional Sales Manager at CDx Diagnostics® since November 2016, Brendan plays a critical role in driving sales for an advanced diagnostic platform aimed at detecting precancerous cells. Prior roles include Vice President of Sales at DC Group, where Brendan led sales efforts to support venture capital and private equity firms, and District Sales Manager at TriReme Medical, focusing on coronary artery disease devices in the New England market. Brendan also held positions at Apollo Endosurgery and Boston Scientific, gaining extensive experience in relationship management and sales execution in various medical environments. Earlier, Brendan was involved in 401(k) consulting and training at Paychex and held roles in education and the Air National Guard. Brendan earned a degree in Sociology and Criminal Justice from Bowling Green State University.
This person is not in any offices
CDx Diagnostics®
The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods.